Latest News
Provention’s success with T1D-delaying mAb will contend with the need to develop screening protocols
Provention’s success with T1D-delaying mAb will contend with the need to develop screening protocols
- April 05, 2021Source: Medicine@Yale
YSM’s clinical, scientific, and educational efforts all overcame major challenges.
- April 01, 2021
Lieping Chen, MD, PhD, has been elected as a Fellow of the American Association for Cancer Research (AACR) Academy.
- March 31, 2021
Yale School of Medicine students, in collaboration with a diverse set of other students and community members, are playing a significant role in the vaccination campaign in New Haven, in Connecticut, and nationally.
- March 24, 2021
David Schatz is Speaking the University of New Haven: "The Genome as Playground: Jumping Genes and the Evolution of the Immune System"
- March 22, 2021Source: MD alert
Teplizumab delays onset of type 1 diabetes in half of high-risk individuals
- March 19, 2021Source: YaleNews
Yale researchers found the immune system not only defends against pathogens but regulates which nutrients are taken in.
- March 19, 2021Source: Yale Daily News
Researchers at the Yale School of Medicine have isolated from blood samples specialized immune cells that attack tumors and could serve as a way to monitor the success of cancer treatments.
- March 15, 2021Source: Yale Medicine
Yale's Akiko Iwasaki, PhD, discusses her COVID-19 research and answers commonly asked COVID-19 questions.
- March 15, 2021Source: Yale Daily News
Now that COVID-19 vaccines are being rolled out for adults in much of the world, pharmaceutical companies have started to conduct further trials to confirm whether the shots are also safe and effective for children and pregnant women.